| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/2006 | US20060167103 Methods of treating cancer with HDAC inhibitors |
| 07/27/2006 | US20060167067 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166941 Treatment and/or prevention of non-viral epithelial damage |
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166915 Human coagulation factor VII polypeptides |
| 07/27/2006 | US20060166911 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 07/27/2006 | US20060166910 Rna-interference by single-stranded rna molecules |
| 07/27/2006 | US20060166909 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 07/27/2006 | US20060166897 Novel indazole peptidomimetics as thrombin receptor antagonists |
| 07/27/2006 | US20060166896 Novel indazole peptidomimetics as thrombin receptor antagonists |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060166894 Ace-inhibitors having antioxidant and no-donor activity |
| 07/27/2006 | US20060166893 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments |
| 07/27/2006 | US20060166892 Treatment of cell proliferative disorders with chlorotoxin |
| 07/27/2006 | US20060166891 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/27/2006 | US20060166890 Non-t cell binding peptides and their uses |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166888 for arachidonic acid release in target cells; intracellular calcium release; phospholipases |
| 07/27/2006 | US20060166887 recruiting neurons to the brain, and treating a neurodegenerative condition by injecting nucleic acid construct intraventricularly into subject's brain; Huntington's Disease |
| 07/27/2006 | US20060166886 Polyethylene glycol-albumin colloid that reduces the risk of organ injury and treats hypovolemic conditions by restoring vascular volumes; treating multiorgan dysfunction (MODS), related to systemic inflammatory response syndrome (SIRS); pegylated albumin has an extended useful half-life |
| 07/27/2006 | US20060166885 Treatment and prevention of decubitus |
| 07/27/2006 | US20060166884 Purified rhlGF-I/rhlGFBP-3 complexes and their method of manufacture |
| 07/27/2006 | US20060166883 Novel antimicrobial peptides based on tripeptide repeats |
| 07/27/2006 | US20060166882 Liquid, aqueous pharmaceutical composition of Factor VII polypeptides |
| 07/27/2006 | US20060166880 Control a mechanism of intracellular release of calcium, to control signal transmission in which intracellular calcium is involved; to control intracellular calcium release by carbonic anhydrase-related protein (CARP), to regulate or diagnose activity of IP3R |
| 07/27/2006 | US20060166879 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 07/27/2006 | US20060166878 treating a disease or disorder/condition associated with VEGF-induced neovascularization or angiogenesis; for topical application to the skin or to the eye |
| 07/27/2006 | US20060166877 Methods of protecting against radiation damage using alpha thymosin |
| 07/27/2006 | US20060166876 Delocalization molecules and use thereof |
| 07/27/2006 | US20060166875 Single chain recombinant t cell receptors |
| 07/27/2006 | US20060166874 Fvii or fviia variants having increased clotting activity |
| 07/27/2006 | US20060166873 Preventive/remedy for arteriosclerosis |
| 07/27/2006 | US20060166872 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia |
| 07/27/2006 | US20060166871 Medical compositions containing ghrelin |
| 07/27/2006 | US20060166870 Treatment of glioblastoma with thymosin-alpha 1 |
| 07/27/2006 | US20060166869 Novel use of lipopeptide preparations |
| 07/27/2006 | US20060166868 Vegf peptides and their use |
| 07/27/2006 | US20060166867 Argininamido-neomycin B conjugates; aminoglycoside antibiotics; for prevention and treatment of HIV infection |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/27/2006 | US20060166865 A modified nucleoside comprising a purine ring for treating viral infections |
| 07/27/2006 | US20060166864 Methods for modulating telomerase activity |
| 07/27/2006 | US20060166863 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/27/2006 | US20060166862 Comprising a transcobalamin (TC) binding carrier and a therapeutic and/or diagnostic agent linked directly or through linker to the TC binding carrier; highly and efficiently absorbed |
| 07/27/2006 | US20060166861 Inclusion compound of porphyrin metal complex and albumin |
| 07/27/2006 | US20060166860 Zinc transporter compositions for the treatment of cardiovascular diseases |
| 07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
| 07/27/2006 | US20060166858 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/27/2006 | US20060166329 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 07/27/2006 | US20060166327 G-protein chemokine receptor; use in drug screening and diagnosis of conditions related to the underexpression of the G-protein coupled receptor polypeptides by detecting a mutation |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |
| 07/27/2006 | US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2006 | US20060166255 Methods of using 48149, a human Aminopeptidase family member |
| 07/27/2006 | US20060166225 Methods and compositions for polypeptide engineering |
| 07/27/2006 | US20060166220 having apoptotic activity; exhibited anti-proliferative activity when expressed in transformed cells |
| 07/27/2006 | US20060166209 Growth hormone variations in humans and its uses |
| 07/27/2006 | US20060166202 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
| 07/27/2006 | US20060166198 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 07/27/2006 | US20060166194 Diagnosis and treatment of cancer |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060166186 Detecting a compartment or a macromolecule of a cell by expressing a polynucleotide encoding chimeric polypeptide in the cell having single chain Fv region that binds a detectable molecule and a S-AKAP84 region that binds the macromolecule or targets the compartment; exposing cell to molecule; analyzing |
| 07/27/2006 | US20060165810 Controlled release from block co-polymer worm micelles |
| 07/27/2006 | US20060165808 Microcapsules for the delayed, controlled release of perindopril |
| 07/27/2006 | US20060165778 Enteric composition for the manufacture of soft capsule wall |
| 07/27/2006 | US20060165773 Gene therapy of tumors using non-viral delivery system |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165726 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like |
| 07/27/2006 | US20060165714 Peptides for vaccination against human CMV |
| 07/27/2006 | US20060165710 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 07/27/2006 | US20060165709 stimulate T cytotoxic lymphocytes in a mammal |
| 07/27/2006 | US20060165704 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 07/27/2006 | US20060165696 Remedy for spinal injury containing interleukin-6 antagonist |
| 07/27/2006 | US20060165694 Fab fragments and their DNA sequences used for preparation of complete recombinant Anti-Rhesus D antibodies; biodrugs; medical diagnosis |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165683 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 07/27/2006 | US20060165679 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2) |
| 07/27/2006 | US20060165674 Granular composition and process for producing the same |
| 07/27/2006 | US20060165673 proteins having transferase activity comprising amino acid sequences modified to be in detectably labeled form, used for therapy and drug screening |
| 07/27/2006 | US20060165672 Fatigue reducing agent |
| 07/27/2006 | US20060165671 Novel nutraceutical compositions comprising epigallocatechin gallate |
| 07/27/2006 | US20060165656 Medicinal preparation having chemotherapeutic encapsulated therein |
| 07/27/2006 | US20060165655 4-Amino-7- beta -(2'-C-methyl-D-ribofuranosyl)-furo[3,2-d]pyrimidine; anticancer agents |
| 07/27/2006 | US20060165654 Peptides and recombinant proteins mimicking interferons |
| 07/27/2006 | US20060165653 Use of Fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/27/2006 | US20060165652 Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| 07/27/2006 | US20060165651 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/27/2006 | US20060165650 Rantes-derived peptides with anti-hiv activity |
| 07/27/2006 | US20060165649 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 07/27/2006 | US20060165647 Immunosuppressive substance adsorbent, extracorporeal cicrulation column and method of treating cancer |
| 07/27/2006 | US20060165618 Photoactivatable composition and uses thereof |
| 07/27/2006 | US20060165593 Tc and re labeler radioactive glycosylated octreotide derivatives |
| 07/27/2006 | US20060163393 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |
| 07/27/2006 | DE20023785U1 Composition useful for e.g. treating nervous system disorders, comprising botulinum neurotoxin, is free from natural complexing proteins and is not antigenic |
| 07/27/2006 | DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications |
| 07/27/2006 | CA2598607A1 Methods and compositions for cell-cycle regulation |
| 07/27/2006 | CA2595795A1 Use of soluble cd164 variants in inflammatory and/or autoimmune disorders |
| 07/27/2006 | CA2595414A1 Hiv-1 gp41 fusion peptides for immunomodulation |
| 07/27/2006 | CA2595406A1 Mucin hypersecretion inhibitors based on the structure of mans-related peptides and methods of use |
| 07/27/2006 | CA2595004A1 Remedy for nerve cell regeneration |